Our Funding Opportunities
Our current funding opportunities that are available to help progress research in Rare Disease at Newcastle University.
Current Call - LifeArc PathFinder
A huge congratulations to our six LifeArc Pathfinders Award 2022 winners!
John A. Sayer - Use of antisense oligonucleotides as personalised therapies for kidney disease.
Andrew Blamire - Magnetic Resonance Imaging (MRI) of motor unit dynamics as a non-invasive disease biomarker in Spinal Muscular Atrophy (SMA).
Kevin J. Marchbank - Homodimeric mini-FH gene therapy: safety, efficacy and added value.
Sophie Hambleton, Rui Chen, Wyatt Yue and Kate Madden - From RAGs to riches: modulating recombinase function to rescue T cell development in rare inborn errors of immunity.
Helen Devine - Targeting Bile Acid Receptors in Motor Neuron Disease: Pre-clinical Modelling to Assess the Potential of Repurposing FXR and TGR5 Receptor Agonists as Therapeutic Agents in MND.
Giles Holt - Targeted long-read sequencing of the RCA cluster to personalise management of atypical haemolytic uraemic syndrome
We had an incredible 36 applications from across our membership, with the panel having the difficult job of choosing just six of these to fund. A massive thank you to everyone for their time, effort and enthusiasm for this Award, one of many opportunities we hope to bring our members in the coming years.